Application Nr Approved Date Route Status External Links
ANDA090246 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Lamivudine And Zidovudine Tablet, A Combination Of 2 Nucleoside Analogue Reverse Transcriptase Inhibitors, Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. ( 1 ) Lamivudine And Zidovudine Tablet, A Combination Of 2 Nucleoside Analogues, Is Indicated In Combination With Other Antiretrovirals For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Lamivudine LAMIVUDINE ZINC12346
2. Zidovudine ZIDOVUDINE ZINC3779042

Comments